{"id":3296,"date":"2025-10-06T05:52:40","date_gmt":"2025-10-06T05:52:40","guid":{"rendered":"https:\/\/genoks.com.tr\/docs\/hereditary-cancer-genoxhere-me\/"},"modified":"2026-05-01T21:43:16","modified_gmt":"2026-05-01T21:43:16","password":"","slug":"hereditary-cancer-genoxhere-me","status":"publish","type":"docs","link":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/","title":{"rendered":"\u0160ta je nasledni rak i GenoXhere?"},"content":{"rendered":"<p><!--genoks-intro-me:start--><\/p>\n<p><strong>\u0160ta je nasledni rak i GenoXhere?<\/strong><\/p>\n<p>Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni karcinom \u0161titnja\u010de, retinoblastom). Identifikacija naslednog raka omogu\u0107ava ciljani nadzor, hirurgiju koja smanjuje rizik, hemoprevenciju i pristup molekularnoj ciljanoj terapiji (npr. PARP inhibitori za rakove povezane sa BRCA).<\/p>\n<p><strong>Onkolo\u0161ki panel GenoXhere<\/strong> pru\u017ea sveobuhvatnu germinativnu analizu gena predisponiraju\u0107ih za rak visoke i umjerene penetrabilnosti uklju\u010duju\u0107i BRCA1, BRCA2, PALB2, ATM, CHEK2, TP53, PTEN, CDH1, STK11, MLH1, MSH2, MSH6, PMS2, EPCAM, APC, MUTYH, VHL, RET, MEN1 i druge. Panel se nudi u dvije konfiguracije: <strong>Prime 160 gena<\/strong> za op\u0161tu procjenu naslednog raka i <strong>Plus 360 gena<\/strong> za pro\u0161ireno hematolo\u0161ko i pokri\u0107e rijetkih karcinoma. Uzorak: 2-4 mL periferne krvi sa EDTA. Vrijeme izvje\u0161taja: 8 nedjelja (\u00b12). Rezultati se interpretiraju prema ACMG\/AMP 2015 klasifikaciji varijanti, a posttestna genetska konsultacija je obavezna.<\/p>\n<p><!--genoks-intro-me:end--><\/p>\n<p style=\"text-align: justify\"><strong>Herediter Kanser Nedir?<\/strong><\/p>\n<p style=\"text-align: justify\">Herediter kanser, bir ki\u015finin genetik materyalindeki belirli bir mutasyon nedeniyle kansere yakalanma riskinin artt\u0131\u011f\u0131 bir t\u00fcr kanserdir. Bu mutasyonlar, bir ki\u015finin do\u011fumundan itibaren var olan genetik de\u011fi\u015fikliklerdir ve bu de\u011fi\u015fiklikler kanser h\u00fccrelerinin geli\u015fmesine ve b\u00fcy\u00fcmesine neden olabilir. GenoXhere ise heretider kanserlere kar\u015f\u0131 Genoks Genetik Hastal\u0131klar De\u011ferlendirme Merkezi&#8217;nin onkoloji panelidir.<\/p>\n<p style=\"text-align: justify\">Herediter kanser, \u00f6zellikle ailede birden fazla kanser vakas\u0131n\u0131n g\u00f6r\u00fcld\u00fc\u011f\u00fc durumlarda d\u00fc\u015f\u00fcn\u00fclmelidir. \u00d6rne\u011fin, meme kanseri, over kanseri, kolon kanseri, pankreas kanseri ve baz\u0131 l\u00f6semi t\u00fcrleri gibi baz\u0131 kanserler, herediter kanser sendromlar\u0131na neden olabilir.<\/p>\n<p style=\"text-align: justify\">Herediter kanser sendromlar\u0131, \u00f6zellikle kanser geli\u015fimi a\u00e7\u0131s\u0131ndan y\u00fcksek risk ta\u015f\u0131yan ki\u015filer i\u00e7in d\u00fczenli taramalar ve erken te\u015fhisin sa\u011flanmas\u0131na yard\u0131mc\u0131 olacak genetik testler yoluyla tan\u0131mlanabilir. Bu ki\u015filer, kanser geli\u015fimi a\u00e7\u0131s\u0131ndan risk alt\u0131nda olduklar\u0131 i\u00e7in, sa\u011fl\u0131kl\u0131 ya\u015fam tarz\u0131 de\u011fi\u015fiklikleri, d\u00fczenli taramalar ve gerekirse tedavi se\u00e7enekleri gibi \u00f6nlemler alarak kanser risklerini azaltabilirler.<\/p>\n<p style=\"text-align: justify\"><strong>GenoXhere Nedir?<\/strong><br \/>\nGenoXhere; heretider kanserlere kar\u015f\u0131 Genoks Genetik Hastal\u0131klar De\u011ferlendirme Merkezi&#8217;nin onkoloji panelidir. GenoXhere, <a href=\"https:\/\/genoks.com.tr\/genetik_bilgi_bankas\u0131\/genoxhere-prostat-kanseri\/\">GenoXhere Prostat<\/a>, <a href=\"https:\/\/genoks.com.tr\/genetik_bilgi_bankas\u0131\/genoxhere-meme-over-kanseri\/\">Genoks Meme \/ Over<\/a>, <a href=\"https:\/\/genoks.com.tr\/genetik_bilgi_bankas\u0131\/genoxhere-kolon-23-gen\/\">GenoXhere Kolon 23 Gen<\/a> ve <a href=\"https:\/\/genoks.com.tr\/genetik_bilgi_bankas\u0131\/genoxhere-brca\/\">GenoXhere BRCA<\/a> panellerinin yan\u0131 s\u0131ra Prime 160 Gen ve Plus 360 Gen olmak \u00fczere iki farkl\u0131 paket ile sunulmaktad\u0131r.<\/p>\n<p style=\"text-align: justify\"><strong>GenoXhere Prime 160 Gen <\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td><strong>Gen :<\/strong><\/td>\n<td>ABCB11 | AIP | ALK | ANKRD26 | APC | ATM | ATR | AXIN2 | BAP1 | BARD1 | BLM | BMPR1A | BRAF | BRCA1, BRCA2 | BRIP1 | CASR | CBL | CDC73 | CDH1 | CDK4 | CDKN1B | CDKN1C | CDKN2A | CEBPA | CEBPE | CEP57 | CFTR | CHEK2 | COL7A1 | CTC1 | CTRC | CYLD | DDB2 | DICER1 | DIS3L2 | DKC1 | DOCK8 | EGFR | EGLN1 | ELANE | EPCAM | ERCC1 | ERCC2 | ERCC3 | ERCC4 | ERCC5 | EXO1 | EXT1 | EXT2 | EZH2 | FAH | FANCA | FANCB | FANCC | FANCD2 | FANCE | FANCF | FANCG | FANCI | FANCL | FANCM | FH | FLCN | G6PC3 | GALNT12 | GATA2 | GBA | GJB2 | GPC3 | GREM1 | HAX1 | HFE | HMBS | HNF1A | HOXB13 | HRAS | ITK | KIF1B | KIT | KITLG | KRAS| MAP2K1 | MAP2K2 | MAX | MC1R | MEN1 | MET | MITF | MLH1 | MLH3 | MPL | MRE11 | MRE11A | MSH2 | MSH3 | MSH6 | MTAP | MUTYH | NBN | NF1 | NF2 | NHP2 | NOP10 | NPAT | NRAS | NSD1 | NSUN2 | NTHL1 | PALB2| PALLD | PAX5 | PDGFRA | PHOX2B | PMS1 | PMS2 | POLD1 | POLH | PPM1D | PRF1 | PRKAR1A | PRSS1 | PTCH1 | PTCH2 | PTEN | PTPN11 | RAD50 | RAD51C | RAD51D | RAF1 | RB1 | RECQL4 | RET | RHBDF2 | RMRP | RUNX1 | SAMD9 | SBDS | SDHA | SDHAF2 | SDHB | SDHC | SDHD | SERPINA1 | SH2D1A | SHOC2 | SLC25A13 | SLC45A2 | SLX4 | SMAD4 | SMARCA4 | SMARCB1 | SMARCE1 | SOS1 | SPINK1 | SPRED1 | SRP72 | STK11 | SUFU | TERC | TERT| TINF2 | TMEM127 | TP53 | TSC1 | TSC2 | TYR | VHL | WRAP53 | WRN | WT1 | XPA | XPC | XRCC2 | XRCC2<\/td>\n<\/tr>\n<tr>\n<td><strong>Y\u00f6ntem :<\/strong><\/td>\n<td>NGS<\/td>\n<\/tr>\n<tr>\n<td><strong>Raporlama S\u00fcresi :<\/strong><\/td>\n<td>8 Hafta (+\/- 2 Hafta)<\/td>\n<\/tr>\n<tr>\n<td><strong><strong>Prenatal\/ Postnatal:<\/strong><\/strong><\/td>\n<td>Postnatal<\/td>\n<\/tr>\n<tr>\n<td><strong>Gerekli Numune<\/strong>:<\/td>\n<td>EDTA&#8217;l\u0131 Kan (2-4 ml)<\/td>\n<\/tr>\n<tr>\n<td><strong>Saklamama \/ Ta\u015f\u0131ma S\u0131cakl\u0131\u011f\u0131:<\/strong><\/td>\n<td>+ 4C\u00b0\/ + 24C\u00b0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr \/>\n<p style=\"text-align: justify\"><strong>GenoXhere Plus 360 Gen <\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td><strong>Gen :<\/strong><\/td>\n<td>ABCA3 | ABCB7 | ABCG5 | ABCG8 | ACD | ACTB | ACTN1 | ADAMTS13 | AIP | AK1 | AK2 | ALAS2 | ALK | AMN | ANK1 | ANKRD26 | AP3B1 | AP3D1 | APC | ARPC1B | ATM | ATR | ATRX | AXIN2 | BAP1 | BARD1 | BLM | BLOC1S3 | BLOC1S6 | BMPR1A | BRAF | BRCA1 | BRCA2 | BRIP1 | BUB1B | C15ORF41 | C6ORF25 | CBL | CD59 | CD70 | CDAN1 | CDC42 | CDC73 | CDH1 | CDK4 | CDKN1B | CDKN1C | CDKN2A | CEBPA | CECR1 | CEP57 | CHEK2| CLCN7 | CLPB | CSF2RA | CSF3R | CTC1 | CTLA4 | CTNNA1 | CTSC | CUBN | CXCR4 | CYB5R3 | CYCS | CYLD | DDB2 | DDX41 | DHFR | DICER1 | DIS3L2 | DKC1 | DNAJC21 | DNASE2 | DTNBP1 | EFL1 | EGFR | EGLN1 | ELANE | EPAS1 | EPB41 | EPB42 | EPCAM | EPOR | ERCC1 | ERCC2 | ERCC3 | ERCC4 | ERCC5 | ERCC6L2 | ETV6 | EXO1 | EXT1 | EXT2 | EZH2 | F10 | F11 | F12 | F13A1 | F13B | F2 | F5 | F7 | F8 | F9 | FADD | FAM111B | FANCA | FANCB | FANCC | FANCD2 | FANCE | FANCF | FANCG | FANCI | FANCL | FANCM | FAS | FASLG | FGA | FGB | FGG | FH | FLCN | FLI1 | FLNA | FYB | G6PC3 | G6PD | GALNT12 | GATA1 | GATA2 | GBA | GCLC | GFI1 | GFI1B | GGCX | GINS1 | GLRX5 | GP1BA | GP9 | GPC3 | GPI | GPR101 | GPR143 | GREM1 | GSS | HAVCR2 | HAX1 | HBA1 | HBA2 | HBB | HFE | HK1 | HMOX1 | HNF1A | HOXA11 | HOXB13 | HPS1 | HPS3 | HPS4 | HPS5 | HPS6 | HRAS | IFNGR2 | IKZF1 | ITGA2 | ITGA2B | ITGB3 | ITK | JAGN1 | JAK2 | KCNN4 | KIF1B | KIF23 | KIT | KITLG | KLF1 | KRAS | LAMTOR2 | LMAN1 | LPIN2 | LYST | LZTR1 | MAGT1 | MAP2K1 | MAP2K2 | MASTL | MAX | MCFD2 | MECOM | MEN1 | MET | MITF | MKL1 | MLH1 | MLH3 | MPL | MRE11A | MSH2 | MSH3 | MSH6 | MTHFD1 | MTR | MUTYH | MYH9 | MYO5A | NAF1 | NBEAL2 | NBN | NF1 | NF2 | NHP2 | NOP10 | NRAS | NSD1 | NSUN2 | NT5C3A | NTHL1 | OBFC1 | 37257 | P2RY12 | PALB2 | PARN | PAX5 | PC | PDGFRA | PDHA1 | PDHX | PGK1 | PGM3 | PHOX2B | PIEZO1 | PKLR | PMS1 | PMS2 | POLD1 | POLE | POLH | POT1 | PPM1D | PRF1 | PRKACG | PRKAR1A | PROC | PROS1 | PTCH1 | PTEN | PTPN11 | PUS1 | RAB27A | RAC2 | RAD50 | RAD51C | RAD51D | RAF1 | RASA2 | RASGRP2 | RB1 | RBM8A | RECQL | RECQL4 | REN | REST | RET | RHAG | RHBDF2 | RIT1 | RNF168 | RPL11 | RPL15 | RPL26 | RPL27 | RPL31 | RPL35A | RPL5 | RPS10 | RPS19 | RPS20 | RPS24 | RPS26 | RPS28 | RPS29 | RPS7 | RRAS | RTEL1 | RUNX1 | SAMD9 | SAMD9L | SBDS | SDHA | SDHAF2 | SDHB | SDHC | SDHD | SEC23B | SERPINC1 | SERPINF2 | SFTPB | SFTPC | SH2D1A | SHOC2 | SLC11A2 | SLC19A2 | SLC25A38 | SLC37A4 | SLC45A2 | SLC46A1 | SLC4A1 | SLFN14 | SLX4 | SMAD4 | SMARCA4 | SMARCB1 | SMARCD2 | SMARCE1 | SOS1 | SOS2 | SPRED1 | SPTA1 | SPTB | SRC | SRP54 | SRP72 | STAT3 | STK11 | STX11 | STXBP2 | SUFU | TBXA2R | TBXAS1 | TCN2 | TERC | TERT | TF | THBD | THPO | TINF2 | TMEM127 | TMPRSS6 | TP53 | TPI1 | TRIP13 | TRNT1 | TSC1 | TSC2 | TUBB1 | TYR | TYRP1 | UBE2T | UNC13D | USB1 | VHL | VKORC1 | VPS13B | VPS45 | VWF | WAS | WDR1 | WIPF1 | WRAP53 | WRN<\/td>\n<\/tr>\n<tr>\n<td><strong>Y\u00f6ntem :<\/strong><\/td>\n<td>NGS<\/td>\n<\/tr>\n<tr>\n<td><strong>Raporlama S\u00fcresi :<\/strong><\/td>\n<td>8 Hafta (+\/- 2 Hafta)<\/td>\n<\/tr>\n<tr>\n<td><strong><strong>Prenatal\/ Postnatal:<\/strong><\/strong><\/td>\n<td>Postnatal<\/td>\n<\/tr>\n<tr>\n<td><strong>Gerekli Numune<\/strong>:<\/td>\n<td>EDTA&#8217;l\u0131 Kan (2-4 ml)<\/td>\n<\/tr>\n<tr>\n<td><strong>Saklamama \/ Ta\u015f\u0131ma S\u0131cakl\u0131\u011f\u0131:<\/strong><\/td>\n<td>+ 4C\u00b0\/ + 24C\u00b0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr \/>\n<p><strong>Detayl\u0131 Bilgi Almak \u0130\u00e7in Bize Mesaj Atabilirsiniz.<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td>[contact-form-7 id=&#8221;710&#8243; title=&#8221;genetik ba\u015fvuru&#8221;]<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Genoks Genetik Hastal\u0131klar De\u011ferlendirme Merkezi T.C. Sa\u011fl\u0131k Bankanl\u0131\u011f\u0131nca denetlenen ve GHDM-SM\/06.15\/01 ruhsat numaras\u0131 ile hizmet veren sa\u011fl\u0131k kurulu\u015fudur. genoks.com.tr web sayfas\u0131nda bulunan bilgiler, genetik de\u011ferlendirme ve\/veya tan\u0131-te\u015fhis ama\u00e7l\u0131 kullan\u0131lmamal\u0131d\u0131r. T\u00fcm i\u00e7erikler bilgilendirme ama\u00e7l\u0131d\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0160ta je nasledni rak i GenoXhere? Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"doc_category":[210],"doc_tag":[92,105,106,116,122],"class_list":["post-3296","docs","type-docs","status-publish","hentry","doc_category-genoks-gdhm-genetic-tests-me","doc_tag-brca","doc_tag-kalitsal","doc_tag-kanser","doc_tag-mutasyon","doc_tag-postnatal"],"aioseo_notices":[],"year_month":"2026-05","word_count":1157,"total_views":0,"reactions":{"happy":0,"normal":0,"sad":0},"author_info":{"name":"admin","author_nicename":"admin","author_url":"https:\/\/genoks.com.tr\/me\/author\/admin\/"},"doc_category_info":[{"term_name":"Genoks GDHM Genetski testovi","term_url":"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/"}],"doc_tag_info":[{"term_name":"BRCA","term_url":"https:\/\/genoks.com.tr\/docs-tag\/brca\/"},{"term_name":"Kal\u0131tsal","term_url":"https:\/\/genoks.com.tr\/docs-tag\/kalitsal\/"},{"term_name":"kanser","term_url":"https:\/\/genoks.com.tr\/docs-tag\/kanser\/"},{"term_name":"Mutasyon","term_url":"https:\/\/genoks.com.tr\/docs-tag\/mutasyon\/"},{"term_name":"Postnatal","term_url":"https:\/\/genoks.com.tr\/docs-tag\/postnatal\/"}],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 4.9.5.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 4.9.5.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge - Bacamo Svjetlost na Va\u0161e Gene!\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge\" \/>\n\t\t<meta property=\"og:description\" content=\"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-10-06T05:52:40+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-01T21:43:16+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GenoksGHTM\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@Genoks_GHTM\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge\" \/>\n\t\t<meta name=\"twitter:description\" content=\"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@Genoks_GHTM\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/Genoks\\\/#listItem\",\"name\":\"Dok\\u00fcmanlar\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/Genoks\\\/#listItem\",\"position\":2,\"name\":\"Dok\\u00fcmanlar\",\"item\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/Genoks\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs-category\\\/genoks-gdhm-genetic-tests-me\\\/#listItem\",\"name\":\"Genoks GDHM Genetski testovi\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs-category\\\/genoks-gdhm-genetic-tests-me\\\/#listItem\",\"position\":3,\"name\":\"Genoks GDHM Genetski testovi\",\"item\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs-category\\\/genoks-gdhm-genetic-tests-me\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#listItem\",\"name\":\"\\u0160ta je nasledni rak i GenoXhere?\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/Genoks\\\/#listItem\",\"name\":\"Dok\\u00fcmanlar\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#listItem\",\"position\":4,\"name\":\"\\u0160ta je nasledni rak i GenoXhere?\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs-category\\\/genoks-gdhm-genetic-tests-me\\\/#listItem\",\"name\":\"Genoks GDHM Genetski testovi\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/#organization\",\"name\":\"Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge\",\"description\":\"Bacamo Svjetlost na Va\\u0161e Gene!\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/\",\"telephone\":\"+904448732\",\"foundingDate\":\"2014-12-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"value\":160},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/genoks.svg\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#organizationLogo\",\"caption\":\"RapidNIPT testi ile yap\\u0131lan NIPT taramas\\u0131 sayesinde gebelikte 90'dan fazla kromozomal hastal\\u0131k risksiz ve erken d\\u00f6nemde tespit edilir.\"},\"image\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/GenoksGHTM\",\"https:\\\/\\\/x.com\\\/Genoks_GHTM\",\"https:\\\/\\\/www.instagram.com\\\/genoks_ghtm\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/genoks\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74da4ab1a4df3c3e843b41fd6523384c13b4e218e11eb9518da4421619941871?s=96&d=mm&r=g\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#webpage\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/\",\"name\":\"\\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge\",\"description\":\"\\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \\u2014 patogene germinativne varijante u genima predisponiraju\\u0107im za rak koje se nasle\\u0111uju od roditelja. Karakteristike naslednog raka uklju\\u010duju mladu dob nastanka, vi\\u0161e primarnih karcinoma kod iste osobe, vi\\u0161e pogo\\u0111enih \\u010dlanova porodice kroz generacije i rijetke\\\/specifi\\u010dne vrste raka (npr. mu\\u0161ki rak dojke, medularni\",\"inLanguage\":\"cnr-ME\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/docs\\\/hereditary-cancer-genoxhere-me\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2025-10-06T05:52:40+00:00\",\"dateModified\":\"2026-05-01T21:43:16+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/#website\",\"url\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/\",\"name\":\"Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge\",\"description\":\"Bacamo Svjetlost na Va\\u0161e Gene!\",\"inLanguage\":\"cnr-ME\",\"publisher\":{\"@id\":\"https:\\\/\\\/genoks.com.tr\\\/me\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge<\/title>\n\n","aioseo_head_json":{"title":"\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge","description":"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni","canonical_url":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/#listItem","position":1,"name":"Home","item":"https:\/\/genoks.com.tr\/me\/","nextItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/Genoks\/#listItem","name":"Dok\u00fcmanlar"}},{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/Genoks\/#listItem","position":2,"name":"Dok\u00fcmanlar","item":"https:\/\/genoks.com.tr\/me\/Genoks\/","nextItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/#listItem","name":"Genoks GDHM Genetski testovi"},"previousItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/#listItem","position":3,"name":"Genoks GDHM Genetski testovi","item":"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/","nextItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#listItem","name":"\u0160ta je nasledni rak i GenoXhere?"},"previousItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/Genoks\/#listItem","name":"Dok\u00fcmanlar"}},{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#listItem","position":4,"name":"\u0160ta je nasledni rak i GenoXhere?","previousItem":{"@type":"ListItem","@id":"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/#listItem","name":"Genoks GDHM Genetski testovi"}}]},{"@type":"Organization","@id":"https:\/\/genoks.com.tr\/me\/#organization","name":"Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge","description":"Bacamo Svjetlost na Va\u0161e Gene!","url":"https:\/\/genoks.com.tr\/me\/","telephone":"+904448732","foundingDate":"2014-12-01","numberOfEmployees":{"@type":"QuantitativeValue","value":160},"logo":{"@type":"ImageObject","url":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg","@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#organizationLogo","caption":"RapidNIPT testi ile yap\u0131lan NIPT taramas\u0131 sayesinde gebelikte 90'dan fazla kromozomal hastal\u0131k risksiz ve erken d\u00f6nemde tespit edilir."},"image":{"@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/GenoksGHTM","https:\/\/x.com\/Genoks_GHTM","https:\/\/www.instagram.com\/genoks_ghtm\/","https:\/\/www.linkedin.com\/in\/genoks\/"]},{"@type":"Person","@id":"https:\/\/genoks.com.tr\/me\/author\/admin\/#author","url":"https:\/\/genoks.com.tr\/me\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/74da4ab1a4df3c3e843b41fd6523384c13b4e218e11eb9518da4421619941871?s=96&d=mm&r=g"}},{"@type":"WebPage","@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#webpage","url":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/","name":"\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge","description":"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni","inLanguage":"cnr-ME","isPartOf":{"@id":"https:\/\/genoks.com.tr\/me\/#website"},"breadcrumb":{"@id":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/#breadcrumblist"},"author":{"@id":"https:\/\/genoks.com.tr\/me\/author\/admin\/#author"},"creator":{"@id":"https:\/\/genoks.com.tr\/me\/author\/admin\/#author"},"datePublished":"2025-10-06T05:52:40+00:00","dateModified":"2026-05-01T21:43:16+00:00"},{"@type":"WebSite","@id":"https:\/\/genoks.com.tr\/me\/#website","url":"https:\/\/genoks.com.tr\/me\/","name":"Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge","description":"Bacamo Svjetlost na Va\u0161e Gene!","inLanguage":"cnr-ME","publisher":{"@id":"https:\/\/genoks.com.tr\/me\/#organization"}}]},"og:locale":"en_US","og:site_name":"Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge - Bacamo Svjetlost na Va\u0161e Gene!","og:type":"article","og:title":"\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge","og:description":"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni","og:url":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/","og:image":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg","og:image:secure_url":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg","article:published_time":"2025-10-06T05:52:40+00:00","article:modified_time":"2026-05-01T21:43:16+00:00","article:publisher":"https:\/\/www.facebook.com\/GenoksGHTM","twitter:card":"summary_large_image","twitter:site":"@Genoks_GHTM","twitter:title":"\u0160ta je nasledni rak i GenoXhere? - Genoks Genetics | NIPT, Skrining Nosilaca, Onkogenetika i WES Usluge","twitter:description":"\u0160ta je nasledni rak i GenoXhere?Otprilike 5-10% svih karcinoma nastaje na naslednoj osnovi \u2014 patogene germinativne varijante u genima predisponiraju\u0107im za rak koje se nasle\u0111uju od roditelja. Karakteristike naslednog raka uklju\u010duju mladu dob nastanka, vi\u0161e primarnih karcinoma kod iste osobe, vi\u0161e pogo\u0111enih \u010dlanova porodice kroz generacije i rijetke\/specifi\u010dne vrste raka (npr. mu\u0161ki rak dojke, medularni","twitter:creator":"@Genoks_GHTM","twitter:image":"https:\/\/genoks.com.tr\/wp-content\/uploads\/2025\/06\/genoks.svg"},"aioseo_meta_data":{"post_id":"3296","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"seo_analyzer_scan_date":"2026-05-01 21:49:18","breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":null,"created":"2026-05-01 14:34:36","updated":"2026-05-01 22:22:13"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/genoks.com.tr\/me\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/genoks.com.tr\/me\/Genoks\/\" title=\"Dok\u00fcmanlar\">Dok\u00fcmanlar<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/\" title=\"Genoks GDHM Genetski testovi\">Genoks GDHM Genetski testovi<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\u0160ta je nasledni rak i GenoXhere?\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/genoks.com.tr\/me\/"},{"label":"Dok\u00fcmanlar","link":"https:\/\/genoks.com.tr\/me\/Genoks\/"},{"label":"Genoks GDHM Genetski testovi","link":"https:\/\/genoks.com.tr\/me\/docs-category\/genoks-gdhm-genetic-tests-me\/"},{"label":"\u0160ta je nasledni rak i GenoXhere?","link":"https:\/\/genoks.com.tr\/me\/docs\/hereditary-cancer-genoxhere-me\/"}],"_links":{"self":[{"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/docs\/3296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/docs"}],"about":[{"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/types\/docs"}],"author":[{"embeddable":true,"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/comments?post=3296"}],"version-history":[{"count":1,"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/docs\/3296\/revisions"}],"predecessor-version":[{"id":3408,"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/docs\/3296\/revisions\/3408"}],"wp:attachment":[{"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/media?parent=3296"}],"wp:term":[{"taxonomy":"doc_category","embeddable":true,"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/doc_category?post=3296"},{"taxonomy":"doc_tag","embeddable":true,"href":"https:\/\/genoks.com.tr\/me\/wp-json\/wp\/v2\/doc_tag?post=3296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}